N/A N=50 Syncope Decision Aid for Emergency Care
Syncope
Primary: Number of Participants at End of Study — 20; 24 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 2 N=129 The Effect of CPC on Aborting Tilt Induced Syncope in Patients With a History of Vasovagal Syncope or Near Syncope
Syncope, Vasovagal
Primary: Percentage of Participants Who Have Hypotensive Syncope or Near Syncope With SBP Less Than or Equal to 70 mmHG During Tilt Test — 32; 27; 33; 35 Participants — p=0.521
N/A N=39 Ambulatory Post-Syncope Arrhythmia Protection Feasibility Study
Syncope
Primary: Device Unable to Monitor Due to ECG Noise — 1.5 percentage of time worn
N/A N=128 Benefit of Dual-chamber Pacing With Closed Loop Stimulation (CLS) in Tilt-induced Cardioinhibitory Reflex Syncope
Syncope
Primary: Patients With Recurrence of Syncopal Episode — 10; 34 Participants — p=<0.001
N/A N=20 EEG Cap for Identification of Non-Convulsive Status Epilepticus
Nonconvulsive Status Epilepticus · Subclinical Seizure · Altered Mental Status
Primary: Time Difference Between EEG Cap and Standard EEG Results Reporting — 103.4 minutes — p=0.0005
N/A N=36 Emergence From Anesthesia in Anterior Temporal Lobectomy and Amygdalohippocampectomy Patients
Emergence From Anesthesia
Primary: Volumes of the Hippocampus, Thalamus and Amygdala — 3578; 3903; 3479; 3525 mm3
N/A N=3 Cardioneuroablation for Neurocardiogenic Syncope
Neurocardiogenic Syncope · Vasovagal Syncope
Primary: Syncope Recurrence Rate
N/A N=81 PatiEnt Neuropsychological outcomeS After laseR Ablation
Cognitive Change
Primary: Site-determined Cognitive Changes Per Domain — 49; 50.7; 32.9; 35.3 Score
Phase 4 N=210 Clinical Trial for the Prevention of Vasovagal Syncope
Syncope, Vasovagal, Neurally-Mediated
Primary: The Primary Outcome Measure Will be the Recurrence of Syncope in Follow up Period. — 42; 54 Participants
Phase 4 N=35 UNderstanding CONSciousness Connectedness and Intraoperative Unresponsiveness Study
Unconsciousness · Consciousness
Primary: Occipital Delta Power Spectral Density by Conscious State and Study Group. — 2.37; 1.62; 2.05; 2.1 log10(μV^2) — p=0.012
N/A N=86 Diagnostic Yield of an Ambulatory Patch Monitor in Unexplained Emergency Department Syncope: A Pilot Study (PATCH-ED)
Syncope
Primary: Number of Ambulatory Patch Monitor Participants Having Significant Symptomatic Arrhythmia — 9 Participants
N/A N=581 Applicability of Syncope Guidelines in Cataluña
Brief Loss of Consciousness
Primary: Number of Patients That Adhere to the 2009 Syncope Guidelines (ESC2009) — 233 Participants
N/A N=36 EEG Studies of Induction and Recovery From Propofol Induced General Anesthesia
Brain Activity Under Sedation
Primary: EEG Power in Alpha, Slow, and Delta Bands — 10; 0.55; 2.5 Power of alpha band (decibels)
N/A N=15 Stimulation of Cingulo-opercular Alertness Network
Lewy Body Disease · Lewy Body Variant of Alzheimer Disease · Lewy Body Dementia With Behavioral Disturbance
Primary: Dementia Cognitive Fluctuations Scale — 11.75; 8.33 score on a scale — p=<0.001
Phase 4 N=77 ISSUE3: International Study on Syncope of Uncertain Etiology 3
Syncope
Primary: Syncope Recurrence Rate — 57; 25 percentage of participants — p=0.04
N/A N=20 Feasibility of mindBEAGLE in Disorders of Consciousness or Locked-In Syndrome
Consciousness Disorders · Locked-In Syndrome
Primary: Behavioral Diagnosis of Level of Consciousness (LoC) — 0; 23; 2; 23 score on a scale
Phase 2 N=62 Transcranial Direct Current Stimulation in Patients With Disorders of Consciousness
Vegetative State · Minimally Conscious State · Disorders of Consciousness
Primary: Change in CRS-R Total Scores — 12.17; 10.60 units on a scale
N/A N=53 LED Therapy for the Treatment of Concussive Brain Injury
Brain Concussion
Primary: Mean Difference in Change in Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) Score at Baseline and 6 Weeks. — -0.9; -5.78; 3.52; -7.26 Units on a scale
N/A N=498 Delirium in the Emergency Department: Novel Screening
Delirium
Primary: Delirium — 98.0; 56.2; 56.2; 54.8 percent
Phase 2 N=74 Intravenous Lacosamide Compared With Fosphenytoin in the Treatment of Patients With Frequent Nonconvulsive Seizures
Nonconvulsive Seizures
Primary: Percentage of Subjects Who Experience no Nonconvulsive Seizures (NCS) for 24 Hours Following Treatment With LCM vs. fPHT, as Measured by Continuous…
N/A N=20 A Novel Method for Capturing the Visual Evoked Potential During Spine Surgery Under Total Intravenous Anesthesia
Evoked Potentials, Visual
Primary: Number of Participants With Presence of VEPs — 18 Participants
N/A N=52 Rhythmic Light Therapy for Alzheimer's Disease Patients
Mild Cognitive Impairment
Primary: Change in Electroencephalography (EEG) Power at 40 Hertz (Hz) — 3.54; 5.28; 2.83; 4.10 μV2/Hz
N/A N=31 The Effectiveness of Biofeedback for Individuals With Long-term Post-concussive Symptoms
Post-Concussion Syndrome
Primary: Change In SDNN — 43.; 21.87; 19.4 ms
N/A N=3 Low Frequency Electrical Stimulation of the Fornix in Intractable Mesial Temporal Lobe Epilepsy (MTLE)
Mesial Temporal Lobe Epilepsy
Primary: Safety and Tolerability of Low Frequency Stimulation of the Fornix With Regards to Memory Function — 0; 0 Participants
N/A N=20 Head-up Tilt Test in Patients With Reflex Syncope and Asystolic Response Who Received a Dual-chamber Pacemaker With the Closed Loop Stimulation (CLS) and Participated in the BIOSync Trial
Syncope · Syncope, Vasovagal
Primary: Heart Rate [Bpm] at Specific Time-points During Head-up Tilt Test (HUTT) Examination — 70; 88; 105; 95 beats per minute
N/A N=20 Safety and Efficacy of Using SightSaver Visual Evoked Potential (VEP) for VEP Monitoring in Prone Spine Surgery
Ischemic Optic Neuropathy
Primary: Efficacy in Detecting Subtle Intraoperative VEP Changes Using SightSaver Visual Stimulator During Spine Prone Surgeries Under Balanced General Anesthesia Versus TIVA…
N/A N=84 Concussion Testing: A Novel Non-invasive Concussion Detection Device
Concussion
Primary: A Measure Assessing the Sensitivity and Specificity Rate Based on the Nautilus Neurowave Data — 77; 87 percentage of participants